Published in Adv Biomed Res on August 28, 2012
Design and development of intraocular polymeric implant systems for long-term controlled-release of clindamycin phosphate for toxoplasmic retinochoroiditis. Adv Biomed Res (2015) 0.77
Prevalence of Toxoplasma infection in veterinary laboratory sciences students comparing to ordinary people: a case-control study. J Parasit Dis (2014) 0.76
Seroepidemiology of Toxoplasma gondii infection in pregnant women in west Iran: determined by ELISA and PCR analysis. J Parasit Dis (2016) 0.75
Seroprevalence of toxoplasmosis in Korean pregnant women. Korean J Parasitol (2005) 1.62
Serological screening and toxoplasmosis exposure factors among pregnant women in South of Brazil. Rev Soc Bras Med Trop (2005) 1.39
Seroprevalence of six reproductive pathogens in European wild boar (Sus scrofa) from Spain: the effect on wild boar female reproductive performance. Theriogenology (2005) 1.27
HAV in Isfahan province: a population-based study. Trop Gastroenterol (2008) 1.25
Risk factors for Toxoplasma infection in a reproductive age female population in the area of Belgrade, Yugoslavia. Eur J Epidemiol (1998) 1.21
Toxoplasmosis-related knowledge and practices among pregnant women in the United States. Infect Dis Obstet Gynecol (2003) 1.19
Seroepidemiologic evaluation of anti-toxoplasma antibodies among women in north of Iran. Pak J Biol Sci (2007) 1.13
Serologic evaluation of toxoplasmosis in matrimonial women in Babol, Iran. Pak J Biol Sci (2007) 1.07
Seroprevalence of Toxoplasma gondii in unmarried women in Qazvin, Islamic Republic of Iran. East Mediterr Health J (2010) 1.07
Epidemiology of toxoplasmosis among pregnant women in the Paris area. Int J Epidemiol (1988) 1.03
[Prevalence of toxoplasmosis in pregnant women of the province of La Habana]. Rev Inst Med Trop Sao Paulo (1995) 0.89
Seroepidemiology of Toxoplasma gondii among pregnant women in different parts of Sweden. Eur J Epidemiol (1995) 0.86
[Occurrence of toxoplasmosis in pregnant women in Denmark. A study of 5.402 pregnant women]. Ugeskr Laeger (1995) 0.85
Prevalence and Risk Factors of HIV, Syphilis, Hepatitis B and C Among Female Prisoners in Isfahan, Iran. Hepat Mon (2012) 1.33
Seroepidemiology of Toxoplasma gondii infection in Isfahan province, central Iran: A population based study. J Res Med Sci (2011) 1.17
Thoracic computerized tomographic (CT) findings in 2009 influenza A (H1N1) virus infection in Isfahan, Iran. J Res Med Sci (2011) 1.15
Hepatitis C Virus and Associated Risk Factors among Prison Inmates with History of Drug Injection in Isfahan, Iran. Int J Prev Med (2012) 1.08
Immunoglobulin A Nephropathy and Malaria falciparum Infection; a Rare Association. Iran J Public Health (2013) 1.03
Hepatitis B and C among patients infected with human immunodeficiency virus in Isfahan, Iran: seroprevalence and associated factors. Hepat Mon (2010) 1.00
Hepatitis C among Intravenous Drug Users in Isfahan, Iran: a Study of Seroprevalence and Risk Factors. Int J Prev Med (2012) 0.96
Seroprevalence of hepatitis B virus and human immunodeficiency virus among young prisoners. J Res Med Sci (2013) 0.91
Identification of Patients with Hepatitis C Virus Infection in Persons with Background of Intravenous Drug Use: The First Community Announcement-based Study From Iran. Int J Prev Med (2012) 0.88
Clinical features of novel 2009 influenza A (H1N1) infection in Isfahan, Iran. J Res Med Sci (2011) 0.86
High risky behaviors among intravenous drug users in Isfahan, Iran: A study for hepatitis C harm reduction programs. Int J Prev Med (2012) 0.86
Hepatitis D virus infection in Isfahan, central Iran: Prevalence and risk factors among chronic HBV infection cases. Hepat Mon (2011) 0.86
Drug-related mutational patterns in hepatitis B virus (HBV) reverse transcriptase proteins from Iranian treatment-naïve chronic HBV patients. Hepat Mon (2013) 0.85
Hepatitis C virus infection in patients with hemophilia in Isfahan, Iran. Int J Prev Med (2012) 0.84
Hepatitis B and C among women with illegal social behavior in Isfahan, Iran: Seroprevalence and associated factors. Hepat Mon (2011) 0.84
Assessment of quality of life in hepatitis B patients in Iran. Indian J Gastroenterol (2009) 0.83
Comparison of polyomavirus (BK virus and JC viruses) viruria in renal transplant recipients with and without kidney dysfunction. J Res Med Sci (2011) 0.82
Seroprevalence and Risk Factors of Hepatitis C Virus among Juveniles in Correctional Center in Isfahan, Iran. Int J Prev Med (2012) 0.82
Seroprevalence of Hepatitis C Infection among Laboratory Health Care Workers in Isfahan, Iran. Int J Prev Med (2012) 0.81
Seroprevalence of hepatitis a in patients with chronic hepatitis C in isfahan province. Int J Prev Med (2012) 0.80
Isolation of hepatitis C virus in norjizac vials. Hepat Mon (2010) 0.79
Cytochrome P450 2C19 Polymorphism in Iranian Patients with Coronary Artery Disease. ARYA Atheroscler (2011) 0.78
Aspirin resistance and ischemic heart disease on Iranian experience. Adv Biomed Res (2012) 0.77
Surveillance system for hepatitis C infection: A practical approach. Int J Prev Med (2012) 0.77
HIV and other sexually transmitted infections in women with illegal social behavior in Isfahan, Iran. Adv Biomed Res (2012) 0.77
Helicobacter pylori serum antibody titers in patients with cerebral non-cardioembolic ischemic stroke. J Res Med Sci (2011) 0.76
Application of the Random Amplified Polymorphic DNA (RAPD) Fingerprinting to Analyze Genetic Variation in Community Associated-Methicillin Resistant Staphylococcus Aureus (CA-MRSA) Isolates in Iran. Glob J Health Sci (2015) 0.75
Surveillance on the 2009 pandemic influenza A (H1N1) virus, Isfahan, Iran. J Res Med Sci (2011) 0.75
Evaluation of Knowledge and Practice of Hairdressers in Women's Beauty Salons in Isfahan About Hepatitis B, Hepatitis C, and AIDS in 2010 and 2011. Hepat Mon (2013) 0.75
Selective antibody deficiency and its relation to the IgG2 and IgG3 subclass titers in recurrent respiratory infections. Iran J Immunol (2013) 0.75
First report of isolation of Mycobacterium elephantis from bronchial lavage of a patient in Asia. JRSM Short Rep (2011) 0.75
Validation of hepascore as a predictor of liver fibrosis in patients with chronic hepatitis C infection. Hepat Res Treat (2011) 0.75
Central nervous system aspergillosis in an immunocompetent patient. Neurosciences (Riyadh) (2010) 0.75